Abortion Early Clinical Trial
Official title:
Very Early Medical Abortion - a Randomised Controlled Trial
The research question begin addressed by this study is "Is Very Early Medical Abortion (VEMA - before a pregnancy is visible on ultrasound scan) as effective as medical abortion when performed later and an intrauterine pregnancy can be visualised with ultrasound?". This is important to patients and public, because delays to abortion care can cause mental distress, and pain and bleeding are worse at later gestations. The study is examining whether earlier or delayed administration of abortion medications affects the efficacy and side effects of the medical abortion process, in women with very early pregnancies. Any women who had a positive pregnancy test, requesting abortion, but did not have a visible pregnancy on ultrasound scan could take part in the study. Women with signs, symptoms or ultrasound findings suggesting ectopic pregnancy would not be included. This study will be conducted at a community sexual and reproductive health centre that provides abortion care. The participants will be involved in the study for a maximum period of 4 weeks. They will be randomly allocated to either immediate abortion care or delayed abortion care. In each arm of the study they will receive clinical care that they would otherwise routinely receive. In addition to this, they will receive a telephone call follow up with a short questionnaire to complete over the phone. This study is being conducted in Scotland but the results will be combined with findings from similar research groups across Europe as part of a consortium of researchers. This consortium is coordinated by the Karolinska Institutet in Sweden under the EuDRACT ID: 2018-003675-35
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03736681 -
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage
|
Phase 1 | |
| Completed |
NCT03636451 -
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o
|
Phase 3 | |
| Recruiting |
NCT05182008 -
A Patient Decision Aid for Method of Early Abortion: A Randomized Control Trial
|
N/A | |
| Completed |
NCT04432792 -
The California Home Abortion by Telehealth (CHAT) Study
|
||
| Completed |
NCT03417362 -
Delivery of Audiovisual Information on Early Medical Abortion
|
N/A | |
| Completed |
NCT04824118 -
Clotting Parameters After Medical Abortion
|
||
| Recruiting |
NCT04458558 -
Improving Access to Abortion in the Republic of Georgia
|
Phase 4 | |
| Active, not recruiting |
NCT05278780 -
Medication Abortion With Autonomous Self-Assessment Project
|
N/A | |
| Completed |
NCT03320057 -
Medication Abortion Via Pharmacy Dispensing
|
Phase 4 | |
| Not yet recruiting |
NCT05986357 -
The Relation of High Sensitivity C Reactive Protein and Total Leucocytic Count Levels in Threatened Abortion
|
||
| Completed |
NCT03047551 -
Transabdominal and Transvaginal Sonography in Medical Abortion
|
N/A | |
| Completed |
NCT03913104 -
Mail Order Mifepristone Study
|
Phase 4 | |
| Terminated |
NCT04139382 -
Using Telemedicine to Improve Early Medical Abortion at Home
|
N/A | |
| Recruiting |
NCT05147857 -
Mid Trimester Abortion Effectiveness by Dilapan s
|
N/A | |
| Recruiting |
NCT05781061 -
MA-ASAP at Independent Abortion Clinics: A Demonstration Project
|
N/A | |
| Completed |
NCT02522078 -
Dry vs Wet Misoprostol for Cervical Dilation in First Trimester Abortion
|
Phase 4 | |
| Completed |
NCT05635955 -
Remimazolam Versus Propofol for Painless Abortion
|
Phase 2 | |
| Active, not recruiting |
NCT05342974 -
Atorvastatin as a Potential Adjunct to Misoprostol for Termination of Pregnancy
|
Early Phase 1 | |
| Completed |
NCT03900728 -
Auriculotherapy During Medication Abortion
|
N/A |